131 related articles for article (PubMed ID: 19740655)
1. Diastereoisomers of 2-benzyl-2, 3-dihydro-2-(1H-inden-2-yl)-1H-inden-1-ol: potential anti-inflammatory agents.
Sheridan H; Walsh JJ; Cogan C; Jordan M; McCabe T; Passante E; Frankish NH
Bioorg Med Chem Lett; 2009 Oct; 19(20):5927-30. PubMed ID: 19740655
[TBL] [Abstract][Full Text] [Related]
2. Aromatic amide derivatives of 5,6-dimethoxy-2,3-dihydro-1H-inden(-1-yl)acetic acid as anti-inflammatory agents free of ulcerogenic liability.
Sharma M; Ray SM
Bioorg Med Chem Lett; 2007 Dec; 17(24):6790-6. PubMed ID: 17964781
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of amide derivatives of (5,6-dimethoxy-2,3-dihydro-1H-inden-1-yl)acetic acid as anti-inflammatory agents with reduced gastrointestinal ulcerogenecity.
Sharma M; Ray SM
Eur J Med Chem; 2008 Oct; 43(10):2092-102. PubMed ID: 17945398
[TBL] [Abstract][Full Text] [Related]
4. Discovery of N-[(2S)-5-(6-fluoro-3-pyridinyl)-2,3-dihydro-1H-inden-2-yl]-2-propanesulfonamide, a novel clinical AMPA receptor positive modulator.
Ward SE; Harries M; Aldegheri L; Andreotti D; Ballantine S; Bax BD; Harris AJ; Harker AJ; Lund J; Melarange R; Mingardi A; Mookherjee C; Mosley J; Neve M; Oliosi B; Profeta R; Smith KJ; Smith PW; Spada S; Thewlis KM; Yusaf SP
J Med Chem; 2010 Aug; 53(15):5801-12. PubMed ID: 20614889
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics of 2-[4-[(1E)-1-(hydroxyimino)-2,3-dihydro-1H-inden-5-yl]-3-(pyridine-4-yl)-1H-pyrazol-1-yl]ethan-1-ol (GDC-0879), a potent and selective B-Raf kinase inhibitor: understanding relationships between systemic concentrations, phosphorylated mitogen-activated protein kinase kinase 1 inhibition, and efficacy.
Wong H; Belvin M; Herter S; Hoeflich KP; Murray LJ; Wong L; Choo EF
J Pharmacol Exp Ther; 2009 Apr; 329(1):360-7. PubMed ID: 19147858
[TBL] [Abstract][Full Text] [Related]
6. Identification of (R)-1-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)urea (ABT-102) as a potent TRPV1 antagonist for pain management.
Gomtsyan A; Bayburt EK; Schmidt RG; Surowy CS; Honore P; Marsh KC; Hannick SM; McDonald HA; Wetter JM; Sullivan JP; Jarvis MF; Faltynek CR; Lee CH
J Med Chem; 2008 Feb; 51(3):392-5. PubMed ID: 18183945
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and pharmacological profile of a new selective G protein-coupled receptor 119 agonist; 6-((2-fluoro-3-(1-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-4-yl)propyl)amino)-2,3-dihydro-1H-inden-1-one.
Sakairi M; Kogami M; Torii M; Makino M; Kataoka D; Okamoto R; Miyazawa T; Inoue M; Takahashi N; Harada S; Watanabe N
Chem Pharm Bull (Tokyo); 2012; 60(9):1093-5. PubMed ID: 22976315
[TBL] [Abstract][Full Text] [Related]
8. Regioselective synthesis of dispiro[1H-indene-2,3'-pyrrolidine-2',3''-[3H]indole]-1,2''(1''H)-diones of potential anti-tumor properties.
Girgis AS
Eur J Med Chem; 2009 Jan; 44(1):91-100. PubMed ID: 18455272
[TBL] [Abstract][Full Text] [Related]
9. (1S)-1-Phenylethanaminium 4-{[(1S,2S)-1-hydroxy-2,3-dihydro-1H,1'H-[2,2'-biinden]-2-yl]methyl}benzoate.
Frampton CS; Zhang T; Scalabrino GA; Frankish N; Sheridan H
Acta Crystallogr C; 2012 Aug; 68(Pt 8):o323-6. PubMed ID: 22850861
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of some 4-(1H-indol-3-yl)-6-phenyl-1,2,3,4-tetrahydropyrimidin-2-ones/thiones as potent anti-inflammatory agents.
Amir M; Javed SA; Kumar H
Acta Pharm; 2008 Dec; 58(4):467-77. PubMed ID: 19103580
[TBL] [Abstract][Full Text] [Related]
11. Molecular structure studies of (1
Zhang T; Paluch K; Scalabrino G; Frankish N; Healy AM; Sheridan H
J Mol Struct; 2015 Mar; 1083():286-299. PubMed ID: 25750458
[TBL] [Abstract][Full Text] [Related]
12. In vitro inhibition of rat basophilic leukaemia mast cell (RBL-2H3) degranulation by novel indane compounds.
Passante E; Ehrhardt C; Sheridan H; Frankish N
Inflamm Res; 2008; 57 Suppl 1():S15-6. PubMed ID: 18345510
[No Abstract] [Full Text] [Related]
13. Discovery of S-[5-amino-1-(4-fluorophenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxypropoxy)phenyl]methanone (RO3201195), an orally bioavailable and highly selective inhibitor of p38 MAP kinase.
Goldstein DM; Alfredson T; Bertrand J; Browner MF; Clifford K; Dalrymple SA; Dunn J; Freire-Moar J; Harris S; Labadie SS; La Fargue J; Lapierre JM; Larrabee S; Li F; Papp E; McWeeney D; Ramesha C; Roberts R; Rotstein D; San Pablo B; Sjogren EB; So OY; Talamas FX; Tao W; Trejo A; Villasenor A; Welch M; Welch T; Weller P; Whiteley PE; Young K; Zipfel S
J Med Chem; 2006 Mar; 49(5):1562-75. PubMed ID: 16509574
[TBL] [Abstract][Full Text] [Related]
14. Design and microwave-assisted synthesis of 5-trifluoromethyl-4,5-dihydro-1H-pyrazoles: novel agents with analgesic and anti-inflammatory properties.
Sauzem PD; Machado P; Rubin MA; da S Sant'anna G; Faber HB; de Souza AH; Mello CF; Beck P; Burrow RA; Bonacorso HG; Zanatta N; Martins MA
Eur J Med Chem; 2008 Jun; 43(6):1237-47. PubMed ID: 17889969
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a novel, orally active, small molecule gonadotropin-releasing hormone (GnRH) receptor antagonist.
Li H; Anderes KL; Kraynov EA; Luthin DR; Do QQ; Hong Y; Tompkins E; Sun ET; Rajapakse R; Pathak VP; Christie LC; Feng J; Vazir H; Castillo R; Gregory ML; Castro M; Nared-Hood K; Paderes G; Anderson MB
J Med Chem; 2006 Jun; 49(11):3362-7. PubMed ID: 16722655
[TBL] [Abstract][Full Text] [Related]
16. [Unexpected anti-inflammatory activity of rigid structures derived from 6-arylpyridazinone antihypertensive agents. II. Synthesis and activity of 5H-indeno(1,2-c)pyridazine and 5H-indeno(1,2-c)pyridazin-3-one].
Loriga M; Aimé Pinna G; Cignarella G; Schiatti G
Farmaco Sci; 1979 Jan; 34(1):72-80. PubMed ID: 553822
[TBL] [Abstract][Full Text] [Related]
17. A novel domino cyclization for the stereoselective synthesis of indeno[2,1-c]pyran and cyclopenta[c]pyran derivatives.
Subba Reddy BV; Prudhvi Raju N; Someswarao B; Mohan Reddy BJ; Sridhar B; Marumudi K; Kunwar AC
Org Biomol Chem; 2015 Apr; 13(16):4733-6. PubMed ID: 25804904
[TBL] [Abstract][Full Text] [Related]
18. [1a(1a alpha,5 beta,9a alpha)]-1,1a,4,5,7,8,9,9a-Octahydro-3-hydroxy-1,1,2,5- tetramethyl-7-methylene-6H-cyclopropa-[3,4]cyclohept[1,2-e] inden-6-one.
Do Valle NT; De Simone CA; Pereira MA; Goulart MO
Acta Crystallogr C; 2000 May; 56 ( Pt 5)():566-7. PubMed ID: 10851619
[No Abstract] [Full Text] [Related]
19. Synthesis and biological evaluation of some hydroxypyrazole derivatives as anti-inflammatory-antimicrobial agents.
Bekhit AA; Abdel-Rahman HM; Guemei AA
Arch Pharm (Weinheim); 2006 Feb; 339(2):81-7. PubMed ID: 16470641
[TBL] [Abstract][Full Text] [Related]
20. (R)-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT-102) blocks polymodal activation of transient receptor potential vanilloid 1 receptors in vitro and heat-evoked firing of spinal dorsal horn neurons in vivo.
Surowy CS; Neelands TR; Bianchi BR; McGaraughty S; El Kouhen R; Han P; Chu KL; McDonald HA; Vos M; Niforatos W; Bayburt EK; Gomtsyan A; Lee CH; Honore P; Sullivan JP; Jarvis MF; Faltynek CR
J Pharmacol Exp Ther; 2008 Sep; 326(3):879-88. PubMed ID: 18515644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
